Dyadic International, Inc.

NASDAQ:DYAI

Biotechnology

Healthcare
$1.47 +21.49%

+$0.26 today

Market cap
$53.56M
Beta
1.15
P/E (TTM)
-6.9
EPS (TTM)
-$0.20
52W Low $0.65High $1.55

Volume 0.71M

Average 0.31M

DYAI Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Dyadic International, Inc.NASDAQ: DYAI

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables turns positive

Q1 FY2026 accounts payables was $222.7K, compared with -$42.59K a year earlier. Trailing-twelve-month accounts payables was $579.73K.

Context

  • Accounts payables amounted to 25.5% of revenue in FY2025, up 20.4 pp from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near $222.7K or moves back toward the trailing-twelve-month quarterly average of $144.93K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$222.7K+160.7% QoQ
Last fiscal yearDec 2025
$314.45K+274.5% YoY
LTMMar 2026
$579.73K+354.3% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+622.9%——
1 year+274.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
314.45K USD
Year-over-year change
+274.5%
4-year CAGR
-13.0%

Accounts Payables vs competitors

How DYAI compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +354.3% is the 2nd highest of 7, against a peer median of +1.3%.
  • Accounts payables amounts to 19.5% of revenue for DYAI, versus a peer median of 5.8%.
DYAI Competitors
Accounts Payables for DYAI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ANVSAnnovis Bio, Inc.LTM Mar 2026$3.91M USD+242.7%-55.7%—
CELUCelularity Inc.LTM Dec 2025$3.13M USD-60.6%—11.8%
VERUVeru Inc.LTM Mar 2026$2.65M USD+63.2%——
MAIAMAIA Biotechnology, Inc.LTM Mar 2026$1.1M USD+34055.9%+35.0%—
DYAIDyadic International, Inc.LTM Mar 2026$579.73K USD+354.3%—19.5%
RNXTRenovoRx, Inc.LTM Mar 2026$86K USD-85.9%+187.1%5.8%
ATHEAlterity Therapeutics LimitedFY2025A$0 AUD-100.0%—0.0%
PYPDPolyPid Ltd.LTM Dec 2025$0 USD———
Peer median (excluding DYAI) —+1.3%+35.0%5.8%

Competitors are the stored peer set for DYAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(13.07M)(9.74M)(6.8M)(5.81M)(7.36M)
Depreciation & Amortization0000(24.17K)
Deferred Income Tax00000
Stock-Based Compensation1.78M1.89M1.24M1.13M930.18K
Change in Working Capital1.19M(321.17K)(143.21K)754.53K660.8K
Accounts Receivables(13.92K)(47.18K)(93.13K)205.26K(857.85K)
Inventory00000
Accounts Payables549.56K(248.13K)(651.17K)(180.18K)314.45K
Other Working Capital652.59K(25.87K)601.09K729.45K1.2M
Other Non-Cash Items(1.18M)83.71K(1.03M)(46.45K)95.6K
Operating Cash Flow(11.28M)(8.08M)(6.73M)(3.97M)(5.7M)
Capital Expenditures000(4)0
Acquisitions (Net)00000
Purchases of Investments(11.28M)(9.87M)(3M)(7.34M)(5.95M)
Sales of Investments16.51M7.5M10.45M5.47M6.03M
Other Investing Activities00000
Investing Cash Flow5.22M(2.37M)7.45M(1.88M)82.09K
Debt Repayment0005.82M0
Common Stock Issued00024.25K4.96M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities1.23M543.59K000
Financing Cash Flow1.23M543.59K05.85M4.96M
Effect of Forex Changes(63.26K)(44.74K)(2.39K)(5.8K)1.94K
Net Change in Cash(4.89M)(9.95M)720.76K(8.28K)(653.25K)
Free Cash Flow(11.28M)(8.08M)(6.73M)(3.97M)(5.7M)

Dyadic International, Inc.

NASDAQ:DYAI

Intrinsic Alpha fair value

Locked

Current Price

$1.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.